What Cardiometabolic Clinicians Can Be Thankful For This Year
This year, cardiometabolic clinicians have witnessed remarkable advancements for treating patients. Discover now!
5 Most-Cited Takeaways From the 19th Annual Cardiometabolic Health Congress (CMHC)Â
Read on for 5 takeaways from the 19th Annual Cardiometabolic Health Congress – from Dr. Libby’s insights to innovations in renal protection!
MASH and Cardiometabolic Health: Pharmacotherapy and Emerging Therapies (Part 2)
Read on for pharmacotherapy, emerging treatments, & practical strategies for managing MASH in complex patients!
MASH and Cardiometabolic Health: Practical Treatments for Managing Complex Patients (Part 1)Â
Understand key treatment approaches for MASH to stay informed and deliver evidence-based care. Start reading now!
Primary Prevention Takes Center Stage at the 19th Annual Cardiometabolic Health Congress (CMHC)
What happened at the 19th Annual CMHC? Get daily highlights, event photos, and read a poignant quote from keynote Dr. Peter Libby.
Rest, Revive, Repeat: Why Sleep is Critical for Cardiometabolic HealthÂ
Understand the profound connection between sleep disorders and cardiometabolic health. Discover the key to cardiometabolic health!
Creative Alliances in Cardiorenal Metabolic Management: A Game Changer (Part 2)Â
Explore case studies on how creative partnerships and multidisciplinary care improve cardiorenal metabolic risk. Read on!
Creative Alliances in Cardiorenal Metabolic Management: A Game Changer (Part 1)Â
Discover how creative partnerships between patients and healthcare teams can revolutionize care and reduce cardiorenal metabolic risk.
Heart Health Month: The Menopause Transition and Its Effects on Cardiometabolic Risk
Cardiovascular disease (CVD) continues to be the leading cause of death among women who experience a notable increase in disease risk after menopause. Female patients tend to develop coronary heart disease several years later than men leading experts to believe that the menopause transition (MT) contributes to an increase in cardiometabolic risk. However, only 56% […]
A Link Between Tic Disorders & Cardiometabolic Risk?
Findings recently published in JAMA Neurology indicate that patients with Tourette syndrome, or chronic tic disorder (CTD), have an increased risk for developing at least one cardiovascular or metabolic disorder. Researchers from the Karolinska Institutet in Sweden examined data from almost 8,000 individuals with registered diagnoses of TS and CTD—finding that compared with the general […]
